학술논문
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL: Safety Phase Results from Children's Oncology Group Protocol AALL1732
Document Type
Abstract
Author
Source
In Blood 23 November 2021 138 Supplement 1:3398-3398
Subject
Language
ISSN
0006-4971